Dr. Stephen Robert Ruyle , MD
Urology • Denver, CO
2777 Mile High Stadium Cir
Denver, CO 802115222
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 6, 2006; this date does not establish years in practice.
-
Published CMS data list 542 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J9217 — Leuprolide acetate (for depot suspension), 7.5 mg: 316 service units.
- 99214 — Established patient outpatient office visit: 81 service units.
- 96402 — Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle: 63 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 6 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,421 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 263 prescription fills, including refills.
- Orgovyx (Relugolix) — 212 prescription fills, including refills.
- Nubeqa (Darolutamide) — 196 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 15 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 75% of clinicians listed under Urology in Denver, CO (2024, 25 clinicians with data). Median for this group: 1,471. Middle half: 566 to 2,311.
Fewer Medicare Part B services than 80% of clinicians listed under Urology in Colorado (2024, 149 clinicians with data). Median for this group: 1,584. Middle half: 818 to 2,828.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 6,542 in 2020 to 542 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2777 Mile High Stadium Cir
Denver, CO 802115222
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
142 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $74,509 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $52,728 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,503 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$5,358,651 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2024
All general payments: $749.07 across 23 records.
By nature of payment
- Food and Beverage: $749.07 across 23 records.
Reporting-company totals (3 largest of 13)
- Janssen Pharmaceuticals, Inc: $295.72 across 4 records.
- Sumitomo Pharma America, Inc.: $82.55 across 3 records.
- ABBVIE INC.: $64.01 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2024 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ruyle has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ruyle as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Denver and Colorado
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 75% of clinicians listed under Urology in Denver, CO (2024, 25 clinicians with data). Median for this group: 1,471. Middle half: 566 to 2,311.
Fewer Medicare Part B services than 80% of clinicians listed under Urology in Colorado (2024, 149 clinicians with data). Median for this group: 1,584. Middle half: 818 to 2,828.
Medicare-allowed amount
Close to the middle for clinicians listed under Urology in Denver, CO (2024, 25 clinicians with data). Median for this group: $74,509. Middle half: $52,151 to $114,400.
A lower Medicare-allowed amount than 70% of clinicians listed under Urology in Colorado (2024, 149 clinicians with data). Median for this group: $121,564. Middle half: $68,525 to $167,334.
Paid by Medicare
Close to the middle for clinicians listed under Urology in Denver, CO (2024, 25 clinicians with data). Median for this group: $52,728. Middle half: $40,713 to $80,906.
A lower Medicare payment amount than 70% of clinicians listed under Urology in Colorado (2024, 149 clinicians with data). Median for this group: $91,704. Middle half: $49,478 to $124,713.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Urology in Denver, CO (2024, 31 clinicians with data). Median for this group: 808. Middle half: 394 to 1,108.
More Part D prescriptions than 80% of clinicians listed under Urology in Colorado (2024, 172 clinicians with data). Median for this group: 780. Middle half: 468 to 1,213.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Denver, CO (2024, 31 clinicians with data). Median for this group: $95,258. Middle half: $8,487 to $156,971.
A higher Part D drug cost than 95% of clinicians listed under Urology in Colorado (2024, 172 clinicians with data). Median for this group: $78,499. Middle half: $20,294 to $157,486.
52 active clinicians are listed under Urology with a practice address in Denver, CO (249 in Colorado).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Denver
34.6% of these 52 clinicians have the CMS telehealth indicator.
57.7% of these 52 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 92% from 6,542 in 2020 to 542 in 2024.
- 2020: 6,542
- 2021: 7,483
- 2022: 10,469
- 2023: 10,618
- 2024: 542
-
Medicare-allowed amount
Medicare-allowed amount decreased 65% from $215,599 in 2020 to $74,509 in 2024.
- 2020: $215,599
- 2021: $269,104
- 2022: $328,039
- 2023: $272,627
- 2024: $74,509
-
Paid by Medicare
Paid by Medicare decreased 68% from $162,691 in 2020 to $52,728 in 2024.
- 2020: $162,691
- 2021: $204,960
- 2022: $263,945
- 2023: $213,950
- 2024: $52,728
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 1,405 in 2020 and 1,421 in 2024.
- 2020: 1,405
- 2021: 1,490
- 2022: 1,527
- 2023: 1,454
- 2024: 1,421
-
30-day fills
30-day fills decreased 26% from 3,379 in 2020 to 2,503 in 2024.
- 2020: 3,379
- 2021: 3,471
- 2022: 3,433
- 2023: 3,212
- 2024: 2,503
-
Part D drug cost
Part D drug cost increased 684% from $683,656 in 2020 to $5,358,651 in 2024.
- 2020: $683,656
- 2021: $2,492,293
- 2022: $3,070,546
- 2023: $1,854,796
- 2024: $5,358,651
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $901.90 in 2020 to $749.07 in 2024.
- 2020: $901.90
- 2021: $1,681.59
- 2022: $2,140.76
- 2023: $2,402.89
- 2024: $749.07
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): 23 records totaling $749.07.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $136.51 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $121.60 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
OPDIVO | General | $31.98 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $29.70 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $28.68 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $28.58 |
| Tempus AI, Inc |
Food and Beverage
In-kind items and services
|
— | General | $27.94 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $27.25 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $26.75 |
| PROGENICS PHARMACEUTICALS, INC. |
Food and Beverage
In-kind items and services
|
PYLARIFY | General | $26.62 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $25.88 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $25.60 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
SpaceOAR VUE System - 10mL | General | $25.57 |
| PROGENICS PHARMACEUTICALS, INC. |
Food and Beverage
In-kind items and services
|
PYLARIFY | General | $25.14 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $24.64 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $22.82 |
| ACCORD HEALTHCARE, INC. |
Food and Beverage
In-kind items and services
|
CAMCEVI | General | $22.22 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $18.92 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $17.11 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $16.51 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $15.94 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $14.18 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $8.93 |
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
316 | 56 | $354.00 | $178.54 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
81 | 75 | $335.00 | $128.38 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
63 | 58 | $99.00 | $35.86 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
35 | 35 | $235.00 | $91.13 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
32 | 24 | $191.00 | $62.45 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
15 | 15 | $49.00 | $16.28 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 263 | 22,154 | $3,772.59 | 101 |
| Orgovyx | Relugolix | 212 | 6,360 | $563,347.60 | 37 |
| Nubeqa | Darolutamide | 196 | 5,864 | $2,669,024.85 | 28 |
| Abiraterone Acetate | Abiraterone Acetate | 166 | 5,280 | $67,384.16 | 26 |
| Prednisone | Prednisone | 152 | 5,980 | $626.54 | 28 |
| Finasteride | Finasteride | 136 | 11,873 | $1,645.20 | 53 |
| Erleada | Apalutamide | 67 | 2,190 | $1,025,810.99 | — |
| Xtandi | Enzalutamide | 64 | 2,100 | $982,965.28 | 11 |
| Dutasteride | Dutasteride | 53 | 4,650 | $1,517.05 | 21 |
| Myrbetriq | Mirabegron | 37 | 2,700 | $40,580.21 | 13 |
| Solifenacin Succinate | Solifenacin Succinate | 24 | 2,160 | $1,014.85 | — |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | 1,510 | $571.24 | — |
| Alendronate Sodium | Alendronate Sodium | 12 | 1,064 | $55.60 | — |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 12 | 780 | $173.99 | — |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | 400 | $161.33 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20060823000040
CO
4486657921
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
RNNP
Physician Assistant
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated June 06, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Denver
- Dr. Mina Lee, MD
- Dr. Brian Smith, MD
- Dr. Lauren Abrams, MD
- Dr. Brett Abernathy, MD
- Dr. Dustin Ridout, MD
- Dr. John Tillett, MD
Mailing Address
2777 Mile High Stadium Cir
Denver, CO 802115222
Phone: 3038258822